Why Should I Vote On BetterDistricts?

Polling is a powerful tool to help our elected officials determine how they should vote.

Standard polling methods don't give you the control that you deserve. With BetterDistricts you can show your representative exactly how strongly a bill is supported in your community.

Send a clear signal on how you want your government to work.

 

H.R. 5926 - Naloxone Guidelines Act of 2018

Introduced: 2018-05-23
Bill Status: Referred to the House Committee on Energy and Commerce.
 
Summary Not Available

Full Text


115th CONGRESS
2d Session
H. R. 5926


    To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

May 23, 2018

    Mr. Keating (for himself and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

    To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Naloxone Guidelines Act of 2018”.

SEC. 2. Guidelines for prescribing naloxone.

(a) In general.—Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug.

(b) Contents.—In issuing guidelines under subsection (a), the Secretary shall address the following:

(1) Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid.

(2) Dosage safety.

(3) Prescribing an opioid overdose reversal drug to an individual other than a patient.

(4) Standing orders.

(5) Other distribution, education, and safety measures as determined necessary.


Relevant News Stories And Blog Posts

Title Worth Reading

Vote on H.R. 5926

 

Activity in last 30 days